Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.
Saved in:
| Title: | Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study. |
|---|---|
| Authors: | Puri A; Hammersmith Medicines Research Limited, Cumberland Avenue, London NW10 7EW, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), and NIHR Oxford Biomedical Research Centre, Churchill Hospital, Old Road, Headington, Oxford OX3 7LE, UK., Schmidt-Mutter C; Inserm CIC 1434, CHU Strasbourg, 1 Place de l'Hôpital, 67091 Strasbourg, France., Lainé F; Inserm CIC 1414, CHU Rennes, Rue Henri Le Guillou, 35033 Rennes, France., PrayGod G; Mwanza Research Center, National Institute for Medical Research, Isamilo Road, Mwanza P.O. Box 1462, Tanzania., Kibuuka H; Makerere University Walter Reed Project, Plot 42 Nakasero Road, Kampala P.O. Box 16524, Uganda., Barry H; Centre MURAZ, 2054 Avenue Mamadou Konaté, Bobo Dioulasso 01 BP 390, Burkina Faso., Nicolas JF; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, 69364 Lyon, France., Lelièvre JD; INSERM U955, Vaccine Research Institute, CHU Henri Mondor 1 rue Gustave Eiffel, 94000 Créteil, France., Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou 06 BP 10248, Burkina Faso., Kamala B; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania., Manno D; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK., Watson-Jones D; Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 11936, Tanzania.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK., Gaddah A; Janssen Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium., Keshinro B; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Luhn K; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Robinson C; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands., Douoguih M; Janssen Vaccines & Prevention B.V., Archimedesweg 6, 2333 CN Leiden, The Netherlands. |
| Corporate Authors: | EBL4001 Study Group |
| Source: | Vaccines [Vaccines (Basel)] 2024 Feb 17; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines12020210 |
